EP4122926
TRÍAZÍNAFLEIÐUR MEÐ VIRKNI SEM HINDRAR FJÖLGUN VEIRA OG LYFJAFRÆÐILEG SAMSETNING SEM INNIHELDUR ÞÆR SÖMU
:
EP einkaleyfi í gildi á Íslandi:
17.2.2022:
4.6.2025:
22733282.2
:
10.7.2025:
15.8.2025
:
16.2.2042:
16.2.2026
:
TRIAZINE DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
17.2.2022
4.6.2025
10.7.2025
15.8.2025
16.2.2026
:
Shionogi & Co., Ltd.:
1-8, Doshomachi 3-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
:
National University Corporation Hokkaido University:
Kita 8-jyo Nishi 5-chome Kita-ku, Sapporo-shi, Hokkaido 060-0808, JP
:
TACHIBANA, Yuki:
Osaka-shi, Osaka 541-0045, JP
:
UEHARA, Shota:
Osaka-shi, Osaka 541-0045, JP
:
UNOH, Yuto:
Osaka-shi, Osaka 541-0045, JP
:
NAKAHARA, Kenji:
Osaka-shi, Osaka 541-0045, JP
:
TAODA, Yoshiyuki:
Osaka-shi, Osaka 541-0045, JP
:
KASAMATSU, Koji:
Osaka-shi, Osaka 541-0045, JP
:
YAMATSU, Yukiko:
Osaka-shi, Osaka 541-0045, JP
:
ANDO, Shigeru:
Osaka-shi, Osaka 541-0045, JP
:
IIMURO, Atsuhiro:
Osaka-shi, Osaka 541-0045, JP
:
SUTO, Takahiro:
Osaka-shi, Osaka 541-0045, JP
:
SASAKI, Michihito:
Sapporo-shi, Hokkaido 060-0808, JP
:
Novagraaf Brevets:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
:
2021068672:
14.4.2021:
JP
:
2021105802:
25.6.2021:
JP
:
2021153819:
22.9.2021:
JP
:
JP2022006495:
17.2.2022
:
C07D 401/06, A61K 31/506, A61K 31/53, A61K 31/5377, A61K 31/5383, A61K 31/55, A61P 31/14, A61P 43/00, C07D 251/46, C07D 401/04, C07D 401/14, C07D 403/06, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/06, C07D 417/14, C07D 471/04